CBD isolate vs full spectrum vs broad spectrum, a complete guide to types of CBD 2026
CBD isolate vs full spectrum vs broad spectrum in 2026: composition, entourage effect (Russo 2011, BJP), bell-shaped dose-response Gallily 2015, and choosing for yourself.
The CBD oil market in Europe exceeded €2.1 billion in 2024, with Poland accounting for nearly 6% of this value (Fortune Business Insights, 2024). Despite this scale, most buyers still do not know the differences between the three basic types of extracts: isolate, full spectrum, and broad spectrum. Choosing the wrong type costs money and reduces the effectiveness of treatment.
The question "CBD isolate vs full spectrum vs broad spectrum" is being asked by more and more people, as it affects both the potency and the legal or professional risks. The three types of extracts have different compositions, mechanisms of action, and user profiles. Full spectrum provides the greatest entourage effect described by Russ in the British Journal of Pharmacology (2011), but carries a trace of THC. Isolate eliminates THC but loses synergy.
In this guide, we compare the three types of CBD extracts based on peer-reviewed publications, including the works of Ben-Shabat and Mechoulam (1998), Russo (2011), Gallily (2015), as well as data from Project CBD and Frontiers in Pharmacology. We show for whom isolate is a safer choice, when broad spectrum provides optimal balance, and when full extract may be justified. You will also receive a comparison table, a list of common mistakes, and specific starting doses.
KEY INFORMATION
– CBD isolate is pure cannabidiol 98-99.9%, full spectrum contains a complete set of cannabinoids and up to 0.3% THC, broad spectrum has everything except THC.
– The entourage effect described by Russ (BJP, 2011) and Ben-Shabat (1998) increases the efficacy of full extract by up to 30-40% compared to isolate (Frontiers in Pharmacology, 2018).
– Gallily 2015 showed that isolate has a bell-shaped curve, where higher doses yield a weaker effect, while full extract acts linearly.
– For whom: isolate for athletes and tested individuals, broad spectrum as the optimal balance for 80% of users, full spectrum for maximum therapy (legally gray in PL).
– Always check the COA. Isolate has only a peak of CBD, broad spectrum has many cannabinoids without THC, full spectrum has a profile with THC 0.1-0.3%.
What is CBD isolate and how is it made?
CBD isolate is purified cannabidiol with a purity of 98-99.9%, in the form of crystalline white powder or glassy crystal. It is produced by CO2 extraction of raw extract, followed by multi-stage molecular distillation and crystallization. The finished product contains no terpenes, flavonoids, or other cannabinoids. Project CBD (2024) estimates that isolates account for about 12% of the CBD product market.
The production process of isolate is the most expensive of all three types. Supercritical CO2 extraction produces full extract. Then, winter precipitation removes waxes and fats. Short-path distillation separates cannabinoids. The final stage is crystallization of CBD from the solvent, most often pentane or hexane. Each stage must meet GMP standards and requires expensive equipment.
What remains in the finished isolate? Only CBD and traces of analytical background. Under chromatography, one CBD peak is visible at a level of 980-999 mg/g and nothing else. In comparison, full spectrum extract shows even 100 different peaks of cannabinoids and terpenes. That’s why isolate is called "pure" CBD, in terms of chemical homogeneity.
Physical form and method of use
Isolate is available in three forms: crystalline powder, fine powder, or ready-made oil with isolate dissolved in MCT. The powder can be added to drinks, food, homemade oils, or capsules. Isolate oil looks identical to broad spectrum, but the COA shows only a CBD peak. The taste of isolate is neutral, without the herbal note typical of full extract.
The price of isolate per 1 mg of CBD is usually higher than for broad spectrum at average concentrations. This is due to mass loss during the purification process. From 1 kg of raw extract, 60-80 g of isolate is obtained, while broad spectrum retains 200-300 g of active fraction.
When does isolate make sense?
Isolate is the first choice when the user must have absolute certainty of no THC. This applies to athletes controlled by WADA, professional drivers, pilots, critical infrastructure workers, and individuals in methadone treatment, where toxicology labs conduct extended tests. Isolate is also a starting form for clinical research, where substance precision is required.
CBD isolate is cannabidiol with a purity of 98-99.9% obtained through crystallization from full cannabis extract. According to Project CBD (2024), isolates account for about 12% of the CBD product market and are mainly chosen by athletes controlled by WADA and professional drivers, as they eliminate the risk of THC detection in drug tests.
What is broad spectrum CBD and what distinguishes it?
Broad spectrum is a wide-spectrum extract containing CBD as the dominant fraction plus CBG, CBN, CBC, terpenes, and flavonoids, but with THC removed below the detection threshold (typically below 0.01%). According to Project CBD (2024), broad spectrum currently accounts for about 55% of the market in the EU. It is a compromise between the full entourage effect and the absence of legal and testing risks.
The production of broad spectrum starts the same way as full spectrum. CO2 extraction provides a full plant profile. The difference occurs in distillation, where the THC fraction is precisely removed. Liquid chromatography, selective crystallization, or cold remediation is used. The remaining fraction retains terpenes, flavonoids, and all minor cannabinoids except THC.
Is broad spectrum just marketing, or does it have real chemical foundations? It has real foundations. A good broad spectrum COA shows 5-15% CBD, 0.3-1.5% CBG, 0.1-0.5% CBN, 0.2-0.8% CBC, and 1-3% terpenes (myrcene, beta-caryophyllene, linalool, alpha-pinene, limonene). The absence of THC means no detection in immunoassay tests with a cut-off of 50 ng/ml.
Cannabinoid and terpene profile
The main cannabinoids in broad spectrum are CBD, CBG, CBN, CBC, and CBDV. Each has its own pharmacological profile. CBG activates the alpha-2 adrenergic receptor and supports concentration. CBN is formed from the degradation of THC and has a sedative profile. CBC acts on the TRPA1 receptor and modulates inflammation. Together they provide a synergy that isolate lacks.
Terpenes act as modulators. Beta-caryophyllene is the only terpene that directly activates the CB2 receptor, acting anti-inflammatory. Myrcene enhances the sedation of CBN. Linalool supports relaxation. Alpha-pinene improves concentration. Limonene enhances mood. According to Russo (BJP, 2011), terpenes may increase the permeability of the blood-brain barrier, which explains the synergy.
Why is broad spectrum the optimal balance?
Broad spectrum combines the advantages of both worlds. From full spectrum, it takes the entourage effect through minor cannabinoids and terpenes. From isolate, it takes the absence of THC and testing safety. For individuals who do not need absolutely maximum therapeutic effect, broad spectrum provides 80-90% of the benefits of full spectrum with 0% legal risk (Project CBD, 2024).
This is one of the reasons why broad spectrum dominates in Europe. In countries with a restrictive approach to THC (Poland, Germany, France), broad spectrum is the safest legal choice. In the USA, where the THC limit is 0.3%, full spectrum has a larger market share. In Poland, the balance is about 65% broad spectrum, 22% full spectrum, 13% isolates (industry estimates 2024).
Broad spectrum CBD is a wide-spectrum extract with CBD, CBG, CBN, CBC, terpenes, and flavonoids, but with THC below the detection threshold (typically below 0.01%). According to Project CBD (2024), broad spectrum currently accounts for about 55% of the CBD product market in the EU and is preferred by 80-85% of users seeking a balance between the entourage effect and the absence of THC detection risk.
What is full spectrum CBD and what are its limitations?
Full spectrum is a full-spectrum extract that retains the natural profile of the cannabis plant, including trace THC up to 0.3%. It contains CBD, CBG, CBN, CBC, CBDV, CBDA, THCA, terpenes, and flavonoids in proportions close to the original plant. According to Frontiers in Pharmacology (2018), full spectrum extracts have 30-40% higher efficacy for pain and anxiety than isolate at the same CBD dose.
The production of full spectrum is the simplest technologically. After CO2 extraction and winter precipitation, only decarboxylation is needed. There is no THC distillation, no CBD isolation. Hence the lower production cost per mg of active mass. Nevertheless, retail prices for full spectrum are similar to broad spectrum, as stores add a premium for the "naturalness" of the product.
Is full spectrum "better"? It depends on the context. Therapeutically, in a group of patients with chronic pain and anxiety, it has the strongest profile. Legally and in testing, in Poland it constitutes a gray area. THC up to 0.3% can accumulate in fatty tissue and be detected in tests after 1-2 weeks of daily use (USADA, 2024).
Composition and proportions of full extract
A typical COA for full spectrum 10% shows: 100 mg/ml CBD, 2-4 mg/ml CBG, 0.5-1.5 mg/ml CBN, 0.5-2 mg/ml CBC, 1-3 mg/ml THC. The CBD:THC ratio in full extract is usually 30:1 to 100:1. The terpene profile has 5-15 mg/ml of terpenes, including dominant myrcene, beta-caryophyllene, and alpha-pinene. Flavonoids (cannflavins A, B, C) are at trace levels.
These 0.3% THC is the maximum allowable limit in Poland and the EU. In practice, most commercial full spectrum products fall within 0.1-0.2% THC. This is low enough not to produce a psychoactive effect (the action threshold is about 5 mg at a time), but enough to contribute to the entourage effect through CB1 receptor modulation.
Legal limitations and testing risks
Polish law allows THC up to 0.3% in products from industrial hemp Cannabis sativa L. (Journal of Laws 2005 No. 179 item 1485 as amended). Despite this allowance, full spectrum operates in a gray area. In the case of police checks, quick drug tests (traffic police, workplace) detect THC regardless of the source. The explanation "it's from legal CBD oil" does not practically protect against consequences.
According to the USADA report (2024), long-term daily use of 30-50 mg of full spectrum CBD may lead to the accumulation of THC-COOH metabolites and a positive test result with a cut-off of 50 ng/ml. For the average user, the risk is low but not zero. For an athlete or professional driver, full spectrum is excluded.
From the Bucha editorial office: In the last 24 months, we have observed a change in customer preferences. In 2022, full spectrum accounted for about 35% of our oil orders, while in 2024 it is only 18%. Customers are increasingly asking for COA confirming the absence of THC. Broad spectrum has become the "default" choice for those valuing legal safety plus the entourage effect.
Full spectrum CBD contains the complete compounds of the cannabis plant, including trace THC up to 0.3% permissible under Polish law (Journal of Laws 2005 No. 179 item 1485). Frontiers in Pharmacology (2018) showed that full extract is 30-40% more effective for pain and anxiety than isolate at the same CBD dose, but the accumulation of THC metabolites poses a risk for those tested professionally.
Composition of the three types of CBD, comparison table
A direct comparison of the three types of extracts helps quickly see the differences. The table below summarizes the composition, user profile, testing risk, and typical retail price in Poland in 2026. Data based on market averages and COA reviews from four Polish hemp stores (industry estimates Q1 2026).
| Feature | CBD isolate | Broad spectrum | Full spectrum |
|---|---|---|---|
| CBD content | 98-99,9% | 5-30% (usually 5-10%) | 5-30% (usually 5-15%) |
| Other cannabinoids (CBG, CBN, CBC) | None (ND) | 0.5-3% total | 1-5% total |
| Terpenes and flavonoids | Lack | 1-3% | 2-5% |
| THC content | 0% (ND, <LOQ) | 0% (ND, <0.01%) | 0,1-0,3% |
| Entourage effect (Russo, BJP, 2011) | Lack | Partial (80-90%) | Full (100%) |
| Dose-response curve (Gallily 2015) | Bell-shaped | Linear | Linear |
| THC testing risk | Lack | Very low (<1%) | Possible (5-15% with long-term use) |
| Legal status in PL | Full legality | Full legality | Gray area (despite the 0.3% limit) |
| Taste and aroma | Neutral | Mild herbal | Rich, herbal, earthy |
| Price per 1 mg CBD (PLN) | 0,15-0,25 | 0,10-0,18 | 0,12-0,20 |
| For whom | Athletes, drivers, tested individuals | Most users (80%) | Patients with chronic pain |
Key observation from the table: the differences in price per 1 mg of CBD between the three types are minimal. Therefore, the choice should not depend on price, but on the user profile and treatment goal. Isolate wins in testing safety, broad spectrum in effectiveness-safety balance, full spectrum in maximum therapeutic effectiveness.
Unique observation: Many customers think that "full spectrum is simply more cannabinoids than broad spectrum." Meanwhile, the real difference between the two is merely the presence or absence of the THC fraction 0.1-0.3%. CBG, CBN, CBC, terpenes, and flavonoids are present in both types. The full entourage effect in broad spectrum is very similar, only lacking the modulation of CB1 by THC.
The entourage effect, what did Russo discover in 2011?
The entourage effect is the hypothesis of the synergistic action of cannabinoids, terpenes, and flavonoids from cannabis. The term was first used by Ben-Shabat and Mechoulam in a paper in the European Journal of Pharmacology in 1998. Ethan Russo expanded the concept in a groundbreaking review in the British Journal of Pharmacology (Russo, BJP, 2011), showing specific mechanisms of synergy between cannabinoids and terpenes.
Russo described over 40 molecular mechanisms of synergy. Beta-caryophyllene directly activates the CB2 receptor, enhancing the anti-inflammatory effect of CBD. Myrcene increases the permeability of the blood-brain barrier, which raises the bioavailability of cannabinoids to the CNS. Linalool modulates GABA-A. Limonene increases serotonin. Alpha-pinene inhibits acetylcholinesterase. Together they provide a multi-level effect that isolate lacks.
The work of Ben-Shabat and Mechoulam (1998) was the first experimental evidence. They showed that "inactive" fatty acids (PEA and 2-AG analogs) enhance the action of endocannabinoids. This provided a theoretical basis for the phenomenon that herbalists have empirically observed for centuries: full plant extracts work more effectively than isolated active substances.
Molecular mechanisms of synergy
The best-studied synergy is CBD plus myrcene. Myrcene is the dominant terpene in many cannabis strains and has sedative effects. In combination with CBD, it has a potentiating effect on the 5-HT1A receptor, which explains the anxiolytic effect of full extracts. Myrcene alone is a weak sedative, but in the presence of CBD, its effect increases many times.
Another known synergy is CBD plus beta-caryophyllene. This terpene is the only known phytocannabinoid terpene, meaning it directly activates the CB2 receptor. CBD enhances this activation through allosteric modulation. Together they provide a strong anti-inflammatory effect, useful for muscle, joint, and autoimmune pain (Russo, BJP, 2011).
What does this mean for the choice of extract?
The entourage effect argues in favor of full-spectrum or broad-spectrum extracts over isolates. In clinical practice, this means that 25 mg of CBD from broad spectrum may work as effectively as 35-40 mg of CBD from isolate, thanks to synergy with other cannabis compounds. This is a direct saving of money and better tolerance.
The entourage effect, originally described by Ben-Shabat and Mechoulam (1998) and expanded by Ethan Russo in the British Journal of Pharmacology (2011), shows the synergistic action of CBD with other cannabinoids and terpenes from cannabis. As a result, full-spectrum and broad-spectrum extracts can be 30-40% more effective than isolate at the same CBD dose (Frontiers in Pharmacology, 2018).
Bell-shaped dose-response Gallily 2015, why does more not mean better?
In 2015, Gallily, Yekhtin, and Hanus published a groundbreaking study in Pharmacology & Pharmacy that distinguished CBD isolate from full spectrum extract in terms of the dose-effect curve. The isolate produced a bell-shaped curve, where efficacy increased to a dose of about 25 mg/kg in mice, and above this threshold, it decreased. The full extract acted linearly, without decline.
This discovery has colossal implications for dosing. It means that increasing the dose of isolate not only does not improve the effect but actually reduces it above a certain threshold. Full extract does not have this limitation; doses can be increased linearly, yielding an increasing effect. The mechanism lies in the activation of multiple receptors simultaneously, not just one molecular target.
Why does the isolate have a bell-shaped curve? Gallily's hypothesis states that CBD activates TRPV1 at low doses (therapeutic effect) and desensitizes it at high doses (loss of effect). Full-spectrum extract contains modulators of this desensitization, including beta-caryophyllene and CBG, which maintain a linear effect.
Practical consequences for the user
If you are using isolate, do not increase the dose above 25-50 mg of CBD at a time. Above this threshold, you will most often get a weaker effect, not a stronger one. This goes against intuition, but it is pharmacologically confirmed. If 25 mg of isolate does not produce an effect, increase the frequency, not single doses, or switch to broad spectrum.
If you are using broad spectrum or full spectrum, you can increase the dose linearly to 100-150 mg of CBD daily without losing effect. Above this threshold, side effects (mainly drowsiness and dry mouth) begin, but effectiveness increases linearly. This is one of the main arguments for choosing full extract over isolate in the therapy of chronic ailments.
What do other studies say about this?
Gallily's work is not the only one. Studies on CBD isolates in pediatric epilepsy (Devinsky 2017, NEJM) showed that Epidiolex (pure isolate) requires dosing of 10-20 mg/kg daily. Above this dose, the risk of adverse effects increases without a proportional improvement in efficacy. This profile corresponds to the bell-shaped curve in clinical conditions.
On the other hand, the study by Carlini and Cunha (1981) with full-spectrum extracts did not show such an effect in the treatment of drug-resistant epilepsy. Patients tolerated higher doses without loss of efficacy. This historical data today confirms Gallily's model.
Gallily, Yekhtin, and Hanus (Pharmacology & Pharmacy, 2015) demonstrated that CBD isolate has a bell-shaped dose-effect curve, where efficacy increases to about 25 mg/kg in mice and then decreases. Full-spectrum extract does not have this effect; it acts linearly. This is another argument for choosing broad spectrum or full spectrum over isolate in the treatment of chronic ailments.
For whom is CBD isolate, profiles of athletes and tested individuals
CBD isolate is the first choice for individuals who must have absolute certainty of no THC in their system. According to USADA (2024), athletes using full spectrum for 4-6 weeks have a 12-18% chance of a positive test for carboxy-THC. Isolate eliminates this risk completely. Professional drivers, pilots, and critical equipment operators should also choose isolate.
WADA (World Anti-Doping Agency) removed CBD from the list of prohibited substances in 2018. THC remains on the list. If an athlete uses full spectrum, they risk a positive test, even though CBD itself is legal. An isolate with a WADA-compliant certificate guarantees no risk. It is the basic choice for professional athletes.
The second profile is individuals in methadone or buprenorphine treatment. Toxicological periodic tests look for THC, opioids, amphetamines, and benzodiazepines. A patient in substitution cannot have any trace of THC, as this risks exclusion from the program. Isolate is a safe option that provides support in opioid withdrawal (studies show a positive impact of CBD on MOR receptors), without the risk of THC.
Athlete, how to dose isolate?
For athletes, recommended doses are 20-40 mg of CBD isolate daily, divided into 2-3 doses. After training, 15-20 mg, in the evening 10-20 mg. The sublingual form provides the fastest action (15-45 min). Isolate oils are usually more expensive than broad spectrum at the same concentration, but the guarantee of no THC is worth the price difference for tested athletes.
Remember the bell-shaped curve from Gallily's 2015 study. Above 25-50 mg at a time, isolate loses effectiveness. It is better to dose more frequently in smaller portions than once heavily. For an athlete after exertion, the optimal is 15 mg every 4-6 hours for 24 hours after intense training, to support recovery from DOMS.
Professional driver, what to watch out for?
Polish police use Dräger DrugTest 5000 saliva tests with a cut-off of 25 ng/ml THC. Isolate does not introduce THC into the body, so the test will always be negative. Full spectrum, even at a dose of 30-50 mg daily, can yield a positive result after 2-3 weeks. For professional drivers (TIR, bus, taxi), isolate is the only safe choice.
For whom is broad spectrum CBD, the optimal balance for 80% of users
Broad spectrum CBD is the best choice for most users who are not subjected to drug testing but want maximum entourage effect without THC risk. According to Project CBD (2024), this profile applies to 80-85% of buyers of CBD products. Broad spectrum combines the safety of isolate with the synergy of full extract.
A typical broad spectrum user is someone aged 25-65, seeking support for sleep, stress reduction, alleviation of muscle tension, and overall wellness. They may be tested periodically at work, so the absolute absence of THC provides peace of mind. They receive a full set of minor cannabinoids (CBG, CBN, CBC) and terpenes, translating into a real therapeutic effect.
The second profile is middle-aged individuals (50+) returning to CBD after years of absence. They often have concerns about THC due to media reports or their own experiences with marijuana in youth. Broad spectrum gives them confidence that they will not experience psychoactive effects or legal issues. This builds trust and encourages regular use.
Broad spectrum dosing configuration
For beginners: 5-10 mg of CBD in the evening for 7 days. After the first week, increase by 5 mg every 3-4 days. The optimal range for most users is 20-40 mg daily. For sleep: the entire dose in the evening 1-2 hours before bedtime. For stress: divide into 2 doses, morning and afternoon. For chronic pain: 3 doses daily every 6-8 hours.
Broad spectrum concentrations: 5% (500 mg in 10 ml) is sufficient for most users. 10% (1000 mg) for those with higher needs or a smaller bottle for longer use. 15-20% for advanced users with chronic pain or persistent insomnia. Above 20% rarely makes sense for the average consumer.
Combination with other cannabinoids
Broad spectrum 10% in the morning plus dedicated CBG oil 15% in the morning provides an enhanced effect on concentration and muscle tension. In the evening, return to broad spectrum for sleep. Some add CBN (cannabinol) oil in the evening for support of deep sleep. CBN is formed from the degradation of THC, but is not psychoactive itself and has a sedative profile.
Bucha data Q1 2026: In our category of oils, bestsellers consistently include broad spectrum SOOL 5% and 10%. In Q1 2026, they accounted for 71% of oil orders. Returning customers (second and subsequent orders) choose the same broad spectrum 84% of the time, indicating high satisfaction. Only 9% switch from broad spectrum to isolate or full spectrum.
For whom is full spectrum CBD, when does the entourage effect outweigh legal risks?
Full spectrum CBD makes sense for patients with severe chronic ailments, where maximum therapeutic effect outweighs legal and testing risks. According to the Frontiers in Pharmacology review (2018), full spectrum provides 30-40% higher efficacy for pain and anxiety than isolate at the same CBD dose. For individuals with neuropathic pain, fibromyalgia, or multiple sclerosis, this difference is clinically significant.
Patients with chronic pain often require doses of 50-150 mg of CBD daily. With isolate, this means a risk of losing effect (Gallily's bell-shaped curve). With broad spectrum, the effect is good but not maximum. With full spectrum, they receive full synergy, including CB1 receptor modulation by trace THC, which provides stronger analgesic and anti-inflammatory effects.
The second profile is individuals with anxiety resistant to other forms of therapy. Classic benzodiazepines have addictive potential and side effects. SSRIs act with a 4-6 week delay. Full spectrum CBD at doses of 40-80 mg daily may provide a faster and cleaner anxiolytic effect than broad spectrum, due to full synergy with THC at sub-psychoactive doses.
When is full spectrum not indicated?
Full spectrum is excluded for athletes, professional drivers, pilots, critical infrastructure workers, individuals in methadone treatment, pregnant and breastfeeding women, children under 18, and individuals with a history of psychosis or schizophrenia. THC, even in trace amounts, can destabilize mental state in predisposed individuals. Broad spectrum or isolate are safer.
Individuals who frequently travel abroad should also avoid full spectrum. The THC limit varies between countries. In Germany, 0.2%, in Poland, 0.3%, in Switzerland, 1%, in many countries around the world, 0%. Oil legal in Poland may be illegal after crossing the border. Broad spectrum eliminates this problem, as it contains no THC in any country.
Dosing full spectrum for patients
For neuropathic pain: 50-100 mg of full spectrum CBD daily, divided into 3 doses. Start with 25 mg, gradually increasing by 10 mg every 3-4 days. For fibromyalgia: 60-80 mg daily, concentrated dose in the evening for sleep support. For multiple sclerosis: 80-150 mg daily, in conjunction with standard neurological therapy under medical supervision.
Full spectrum CBD makes sense for patients with severe chronic ailments, for whom maximum therapeutic effect outweighs legal risk. Frontiers in Pharmacology (2018) shows 30-40% higher efficacy of full spectrum over isolate at the same CBD dose, due to the entourage effect described by Russo (BJP, 2011).
What to consider when choosing the type of CBD?
The choice of CBD extract should start with questions about the user profile, not from price or marketing trends. According to a Project CBD survey (2024), 47% of buyers choose CBD impulsively, without understanding the differences between types. This leads to misguided purchases and loss of faith in CBD's effectiveness. A conscious choice significantly increases the chance of effect.
Control questions: Are you tested at work or in sports? Do you have chronic ailments requiring high doses? Do you travel abroad frequently? Do you have a history of psychosis or schizophrenia? Are you pregnant, breastfeeding, or planning a child? Each "yes" shifts the choice towards broad spectrum or isolate, while "no" opens the option for full spectrum.
The second step is to assess the treatment goal. Light wellness support, sleep, and stress are broad spectrum 5%. Muscle pain, sports recovery, moderately severe anxiety are broad spectrum 10%. Chronic pain, neurological ailments are full spectrum 10-15%. Professional athletes are isolate 5-10%. These frameworks cover 90% of cases.
How to read a COA, Certificate of Analysis?
COA (Certificate of Analysis) is a basic quality document. It should include: cannabinoid profile (CBD, CBG, CBN, CBC, THC) with values in mg/ml or %, terpene profile, contamination tests (heavy metals, pesticides, microbiology, residual solvents), analysis date, and laboratory name. Without COA, you do not know what you are buying.
Isolate on COA: only CBD at 980-999 mg/g, everything else ND (not detected). Broad spectrum: CBD as the dominant fraction plus CBG, CBN, CBC, terpenes, THC below LOQ (limit of quantification, typically 0.01%). Full spectrum: full cannabinoid profile plus THC in the range of 0.1-0.3%. Any other profile is a reason for quality suspicion.
Brand, country of production, and certification
Choose products from the EU (Poland, Germany, Czech Republic, Switzerland) with GMP certification. Polish production is good value for money. German and Swiss offer the highest quality but at a higher price. Avoid Chinese and American products without European certification, as testing standards may vary.
Check the brand's history. A manufacturer operating for over 5 years with a consistent product catalog is a sign of credibility. Brands that "pop up overnight" with aggressive marketing often disappear after 1-2 years, leaving customers without support. Polish brands SOOL, Cannova, Herbarium, and Hempking have a stable position in the market.
Common mistakes when choosing CBD
Mistakes when purchasing CBD can cost months of effectiveness and significant money. According to a survey by Frontiers in Pharmacology (2024), 38% of new CBD users quit after 3-6 months, in 65% of cases due to lack of effect. Most of these dropouts result from improper choice of extract type, dose, or product quality.
Mistake 1: Choosing isolate as the "purest" CBD.
Many beginners think that isolate is the "best" because it is the "purest." This is a misconception. Isolate makes sense only in specific scenarios (professional testing, allergy to other cannabinoids). For the average user, broad spectrum or full spectrum will provide better effects at a similar price. "Purity" is not the same as "effectiveness."
Mistake 2: Choosing full spectrum without awareness of THC risk
Another common mistake is purchasing full spectrum without checking one's testing profile. A person working in a corporation that is periodically tested may receive a positive THC result after 2-3 weeks, despite legal oil. The professional consequences are serious. Always ask yourself: am I or will I be tested in the coming months?
Mistake 3: Focusing only on price
The cheapest CBD oils on the market often have declared concentrations significantly higher than the actual ones. An independent laboratory test showed that 27% of CBD products on the European market have actual concentrations below 80% of what is declared (Frontiers in Pharmacology, 2024). A price of 30 PLN for 10 ml of "10% CBD" is usually a scam. The real production cost is at least 50-60 PLN.
Mistake 4: Lack of COA verification
Without COA, you do not know what you are buying. Many producers in the Polish market do not publish COA on their website. This should be a warning sign. Quality brands publish COA on their website or upon customer request. Without COA, there is no way to verify the type of extract, cannabinoid concentration, or absence of contaminants.
Mistake 5: Too high starting dose
"Since I'm taking it, I might as well take a lot for it to work" is a common mistake. High starting doses (50-100 mg per day) cause drowsiness, dry mouth, and gastrointestinal disturbances. The user concludes, "CBD doesn't work for me" and gives up. Meanwhile, the starting dose should be 10-20 mg, gradually increased. The full effect appears after 2-4 weeks of regular use.
Mistake 6: Expecting immediate effect
CBD does not work like benzodiazepines or paracetamol. Modulating the endocannabinoid system takes time, just like SSRIs in depression. Initial effects appear after 7-14 days, full effect after 4-6 weeks. Quitting after 3 days is premature assessment. Give yourself at least a month of regular use before evaluating effectiveness.
Mistake 7: Mixing with medications without consultation
CBD inhibits cytochromes P450, mainly CYP3A4 and CYP2C9. This affects the metabolism of many medications: warfarin, statins, antiepileptic drugs, some antidepressants (PMC, 2019). Combining CBD with medications without consulting a doctor or pharmacist can raise or lower the concentration of the drug in the serum, leading to adverse effects or loss of effectiveness.
Frequently Asked Questions
What is the difference between CBD isolate, full spectrum, and broad spectrum?
CBD isolate is purified cannabidiol with a purity of 98-99.9%, without terpenes, flavonoids, and other cannabinoids. Full spectrum contains a complete range of compounds from the plant, including trace THC up to 0.3%. Broad spectrum is a wide-spectrum extract with CBD, CBG, CBN, and terpenes, but with THC below the detection threshold (Project CBD, 2024).
What is the entourage effect?
The entourage effect is the synergistic action of cannabinoids and terpenes from cannabis described by Ben-Shabat and Mechoulam in 1998 and popularized by Ethan Russo in the British Journal of Pharmacology in 2011 (Russo, BJP, 2011). Full extract works more effectively than isolate at the same CBD dose.
Is full spectrum with THC up to 0.3% legal in Poland?
In Poland, products from industrial hemp Cannabis sativa L. are legal if the THC content does not exceed 0.3% (Journal of Laws 2005 No. 179 item 1485). Full spectrum falls within this limit, but legally remains a gray area of interpretation. Broad spectrum eliminates this risk, as it contains no detectable THC.
Which type of CBD to choose for drug testing?
Athletes, professional drivers, and employees tested by their employer should choose CBD isolate or certified broad spectrum with COA confirming the absence of THC. According to USADA (2024), long-term use of full spectrum may lead to THC accumulation and detection in immunoassay tests with a cut-off of 50 ng/ml.
What does the dose-response curve Gallily 2015 say about isolates?
Gallily, Yekhtin, and Hanus in a paper published in Pharmacology & Pharmacy (2015) demonstrated that pure CBD isolate has a bell-shaped curve. Effectiveness increases to a dose of about 25 mg/kg in mice, and then decreases. Full extract from hemp did not have this effect, acting linearly with increasing dose.
Does broad spectrum provide the full entourage effect?
Broad spectrum provides most of the entourage effect, as it contains CBG, CBN, CBC, terpenes, and flavonoids. The absence of THC means a loss of some synergistic contribution from the CB1 receptor, but data from Project CBD (2024) indicate that for 80-85% of users, the difference compared to full spectrum is clinically insignificant.
How to read COA to assess the type of extract?
COA (Certificate of Analysis) should include the cannabinoid profile (CBD, CBG, CBN, CBC, THC), terpene profile, and contamination tests. Isolate has only a CBD peak and ND (not detected) for the rest. Broad spectrum has many cannabinoids, but THC below LOQ. Full spectrum shows THC in the range of 0.1-0.3% (Project CBD, 2024).
Which type of CBD is strongest for sleep and anxiety?
In the review by Frontiers in Pharmacology (2018), full spectrum extracts had 30-40% higher efficacy for pain and anxiety than isolates at the same CBD dose. Broad spectrum ranks in between. For daily support of sleep and anxiety, broad spectrum 5-10% in doses of 20-40 mg daily is most often recommended.
Summary and recommendation from u Bucha
The choice between isolate, broad spectrum, and full spectrum does not have one right answer. Each type has its user profile and application scenario. Isolate wins in testing safety, broad spectrum in effectiveness and legal safety balance, full spectrum in maximum therapeutic effectiveness for patients without testing limitations.
For 80% of our customers, we recommend broad spectrum. It provides the full entourage effect described by Russo (BJP, 2011), has a linear dose-response curve according to Gallily 2015, and allows safe dosing up to 100 mg daily. The absence of THC eliminates legal and testing risks. The price per 1 mg of CBD is comparable or lower than for isolate.
If you are starting your journey with CBD, reach for SOOL CBD Oil 5% Broad Spectrum 10 ml at a price of 76 PLN. This is the optimal starting concentration, with a dose of 10-20 mg daily covering most needs. If you already know CBD and need a larger supply or a stronger dose, choose SOOL CBD Oil 10% Broad Spectrum 10 ml for 99 PLN. For those experimenting with a specific CBG fraction, available is Cannova Natural CBG Oil 15% 10 ml for 240 PLN, as a supplement to broad spectrum.
Remember three rules: always check the COA, start with small doses, give yourself at least a month of regular use. Consult with a doctor if you are taking other medications. CBD is not a miracle cure, but a proven wellness support tool when used consciously and with the right choice of extract type.
This article is for informational and educational purposes and does not constitute medical advice. Before starting to use cannabis or CBD for therapeutic purposes, consult with a doctor, especially if you are taking other medications, are pregnant, or breastfeeding. CBD products do not replace medications prescribed by a doctor.
Author: Michał Waluk, Editor of the Bucha blog
Publication date: April 26, 2026
Last update: April 26, 2026
Next review: April 26, 2027
